Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1997 Apr;6(2):83–84. doi: 10.1080/09629359791767

The puzzling inflammatory bowel disease: growing interest for mediators of inflammation

F J Zijlstra 1
PMCID: PMC2365855  PMID: 18472840

Full Text

The Full Text of this article is available as a PDF (82.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck P. L., Wallace J. L. Cytokines in inflammatory bowel disease. Mediators Inflamm. 1997;6(2):95–103. doi: 10.1080/09629359791785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Derkx B., Taminiau J., Radema S., Stronkhorst A., Wortel C., Tytgat G., van Deventer S. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet. 1993 Jul 17;342(8864):173–174. doi: 10.1016/0140-6736(93)91375-v. [DOI] [PubMed] [Google Scholar]
  3. Elson C. O., Beagley K. W., Sharmanov A. T., Fujihashi K., Kiyono H., Tennyson G. S., Cong Y., Black C. A., Ridwan B. W., McGhee J. R. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance. J Immunol. 1996 Sep 1;157(5):2174–2185. [PubMed] [Google Scholar]
  4. Faulds D., Goa K. L., Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs. 1993 Jun;45(6):953–1040. doi: 10.2165/00003495-199345060-00007. [DOI] [PubMed] [Google Scholar]
  5. Hoang P., Dehennin J. P., Li L., Sibille C., Geubel A., Vaerman J. P. Human colonic intraepithelial lymphocytes regulate the cytokines produced by lamina propria mononuclear cells. Mediators Inflamm. 1997;6(2):105–109. doi: 10.1080/09629359791794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kubes P., Wallace J. L. Nitric oxide as a mediator of gastrointestinal mucosal injury?-Say it ain't so. Mediators Inflamm. 1995;4(6):397–405. doi: 10.1155/S0962935195000640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kucharzik T., Stoll R., Lügering N., Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol. 1995 Jun;100(3):452–456. doi: 10.1111/j.1365-2249.1995.tb03721.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Madretsma S., Wolters L. M., van Dijk J. P., Tak C. J., Feyerabend C., Wilson J. H., Zijlstra F. J. In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells. Eur J Gastroenterol Hepatol. 1996 Oct;8(10):1017–1020. doi: 10.1097/00042737-199610000-00016. [DOI] [PubMed] [Google Scholar]
  9. Miller M. J., Grisham M. B. Nitric oxide as a mediator of inflammation?-You had better believe it. Mediators Inflamm. 1995;4(6):387–396. doi: 10.1155/S0962935195000639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Niessner M., Volk B. A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol. 1995 Sep;101(3):428–435. doi: 10.1111/j.1365-2249.1995.tb03130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pullan R. D., Rhodes J., Ganesh S., Mani V., Morris J. S., Williams G. T., Newcombe R. G., Russell M. A., Feyerabend C., Thomas G. A. Transdermal nicotine for active ulcerative colitis. N Engl J Med. 1994 Mar 24;330(12):811–815. doi: 10.1056/NEJM199403243301202. [DOI] [PubMed] [Google Scholar]
  12. Rhodes J., Thomas G. A. Smoking: good or bad for inflammatory bowel disease? Gastroenterology. 1994 Mar;106(3):807–810. doi: 10.1016/0016-5085(94)90719-6. [DOI] [PubMed] [Google Scholar]
  13. Smith G. S., Rieckenberg C., Longo W. E., Kaminski D. L., Mazuski J. E., Deshpande Y., Miller T. A. The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release. Mediators Inflamm. 1996;5(6):449–452. doi: 10.1155/S0962935196000622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Van Rees E. P., Palmen M. J., Van De Goot F. R., Macher B. A., Dieleman L. A. Leukocyte migration in experimental inflammatory bowel disease. Mediators Inflamm. 1997;6(2):85–93. doi: 10.1080/09629359791776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zijlstra F. J., Srivastava E. D., Rhodes M., van Dijk A. P., Fogg F., Samson H. J., Copeman M., Russell M. A., Feyerabend C., Williams G. T. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut. 1994 Feb;35(2):247–251. doi: 10.1136/gut.35.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Vries J. E. Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med. 1995 Oct;27(5):537–541. doi: 10.3109/07853899509002465. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES